| Assay | LOD SD Δ (ppb) | LOD † (ppb) | Compound | Specificity (CR%) |
|---|---|---|---|---|
| Paxilline | 5 | 62.5 | Paxilline* | 100 |
| Fumonisins | 175 | 2187.5 | Fumonisin B1* Fumonisin B2 Fumonisin B3 |
100 91 100 |
| Ochratoxin A | 0.4 | 5 | Ochratoxin A* | 100 |
| Aflatoxin G1 | 0.5 | 6.25 | Aflatoxin G1* Aflatoxin G2 Aflatoxin B1 Aflatoxin B2 |
100 71 8 5 |
| Diacetoxyscirpenol | 20 | 250 | Diacetoxyscirpenol* | 100 |
| Deoxynivalenol | 80 | 1000 | DON* 3-Acetyl-DON 15-Acetyl-DON DON-3-glucoside |
100 723 3 91 |
| T2/HT2 toxins | 7 | 87.5 | T2 toxin* HT2 toxin |
100 100 |
| Aflatoxin B1 | 0.25 | 3.125 | Aflatoxin B1* Aflatoxin B2 Aflatoxin G1 Aflatoxin G2 |
100 18 15 3 |
| Zearalenone | 5 | 62.5 | Zearalenone* α-Zearalenol β-Zearalenol Zearalanone α-Zearalanol β-Zearalanol |
100 114 69 65 51 52 |

